Posted by AGORACOM
at 10:48 AM on Thursday, January 28th, 2021
Red Light Holland Corp. (CSE: TRIP) (“Red Light Holland” or the “Company“), an Ontario-based corporation engaged in the production, growth and sale of a premium brand of magic truffles to the legal, recreational market within the Netherlands, is pleased to announce that it has closed its previously announced bought deal short form prospectus offering, including the exercise in full of the underwriter’s over-allotment option (the “Offering“). In connection with the Offering, the Company issued 38,334,100 units of the Company (the “Units“) at a price of $0.255 per Unit, for aggregate gross proceeds of $9,775,195. The Offering was conducted by Eight Capital (the “Underwriter“).
“To have Red Light Holland – The People’s Company, being supported by ‘The Suits’ alongside our new and existing shareholders truly strengthens our Psychedelic Movement and our growth. We are so grateful for all of our loyal supporters and we now have over $20 million[1] of capital available which is incredible! This funding will enable us to fully execute on our business plan and the Red Light Holland team will continue working hard towards our goal of developing a leading brand in this emerging industry. Our mission continues – providing legal and responsible adult access now,” said Todd Shapiro, CEO and Director of Red Light Holland.
Posted by AGORACOM-JC
at 10:32 AM on Thursday, January 28th, 2021
Tim Daniels / Executive Chairman of AI/ML Innovations Inc. / (CSE:AIML / OTC:FIRZF) explains how the Toronto-based business is focusing on acquiring and furthering Artificial Intelligence and Machine Learning technologies that can address urgent societal needs.
The firm’s key subsidiary, Health Gauge, is a leading digital health solutions provider that’s poised to disrupt the traditional healthcare industry by providing A.I. innovations and services that improve health outcomes, while at the same time reducing costs and stresses on the overburdened healthcare infrastructure.
AI/ML Highlights:
Recently showcased its proof-of-concept deployment in a study funded by The Bill and Melinda Gates Foundation
Health Gauge aims to penetrate the $245bn global digital health monitoring market by partnering with leading channel partners, health benefits providers, and end-users
Will do this via its proprietary combination of digital health monitoring devices, AI-based software, and cloud computing platform.
Take a seat and learn more about AI/ML and its ambitious vision for the future.
Posted by AGORACOM-JC
at 9:30 AM on Thursday, January 28th, 2021
Phil Waddington / President and CEO of Molecule Holdings Inc. / (MLCL:CSE) discusses the craft-focused, cannabis beverage production company’s cutting-edge work in the nascent Canadian market.
Boasting a 200,000 square foot production facility based in Ontario, the company has just been given the green light to begin selling its unique line of cannabis-infused beverages throughout Canada, starting in Ontario and Québec.
The company’s recent partnership with Vortex Cannabis Inc. allows Molecule to bring its unique line of cannabis-infused beverage products to market this year, while completing its own sales amendment application.
Molecule Highlights:
Molecule’s recent deal with Vortex Cannabis Inc. allows it to begin selling its unique line of cannabis-infused beverages throughout Canada this year.
Vortex will sell products produced by Molecule to provincial retailers, starting with Ontario and Québec.
Molecule has a 200,000 square foot production facility based in Ontario, offering huge capacity.
The company forecasts 2021 Q1 revenue of $3.5m, 2021 Q2 revenue of $5.8m, and a 2021 Run Rate revenue of $18.5m
An early leap of faith into this emerging industry in 2018 has positioned the company well ahead of the pack now.
“We are excited to move into full scale production and sale,” says CEO Phil Waddington.
Posted by AGORACOM
at 7:56 AM on Thursday, January 28th, 2021
Construction of commercial drug manufacturing facility in Germany
Four clinical studies in neurological indications in 2021
Development of oral biosensor and contract development & manufacturing
Psychedelic transdermal and sublingual drug formulation development
VANCOUVER, BC / ACCESSWIRE / January 28, 2021 /XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) (“XPhyto” or the “Company“) is pleased to announce its drug formulation and delivery business strategy and milestones for 2021. As a bioscience accelerator at the leading-edge of the life science industry, XPhyto targets growth through commercialization of its product pipeline and focused investment in impact driven innovation with the potential for meaningful value creation.
Further to XPhyto’s press release dated January 18, 2021, the Company’s core milestones for this year include the commercialization of infectious disease diagnostics, the clinical validation of transdermal and sublingual drug formulations and continued investment in psychedelic medicine.
Regarding XPhyto’s drug formulation business, the Company is pleased to set out the strategy and milestones for 2021 of its wholly owned German subsidiary, Vektor Pharma TF GmbH (“Vektor”). Vektor will position itself for commercial manufacturing, pipeline development and drug formulations for critical mental health conditions.
“2021 is expected to be a transformative year for Vektor. We will be building on significant momentum from 2020 as we advance our drug formulation, contract development, and psychedelic business,” said Prof. Dr. Thomas Beckert, managing director of Vektor Pharma TF GmbH. “The addition of scalable in-house manufacturing capability creates the potential for significant growth across virtually all of our development and commercialization programs.”
Vektor is a German narcotics manufacturer, developer, and researcher located in the district of Biberach, Baden-Württemberg, Germany. For over a decade, the company and its team have been leaders in the design, testing and manufacture of thin film drug formulations, particularly transdermal patches and sub-lingual (oral) strips for the delivery of active pharmaceutical ingredients (“API”) for the treatment of pain and neurological conditions.
Posted by AGORACOM-JC
at 7:42 AM on Thursday, January 28th, 2021
Announced the Company has appointed Tamer Shafik, former Director of Solution Architecture at NTT DATA Corp of Japan (TYO:9613), as its Chief Technology Officer, effective February 8th.
Loop Insights CEO Rob Anson stated: “I am extremely proud that Tamer recognized the opportunity and had the confidence to make the decision to walk away from the comfort and security of his current role at a global leader in NTT Data. Tamer’s decision to join Loop as our CTO truly speaks volumes about where we are headed as a company. Having an established and proven world-class talent capable of driving our technology at a truly global commercialized scale gives me incredible confidence.”
VANCOUVER, British Columbia, Jan. 28, 2021 — Loop Insights Inc. (MTRX:TSXV OTCQB:RACMF) (the “Company” or “Loop”), a provider of contactless solutions and artificial intelligence (“AI”) to drive real-time insights, enhanced customer engagement, and automated contact tracing to the brick and mortar space, is pleased to announce the Company has appointed Tamer Shafik, former Director of Solution Architecture at NTT DATA Corp of Japan (TYO:9613), as its Chief Technology Officer, effective February 8th.
Loop Insights CEO Rob Anson stated: “I am extremely proud that Tamer recognized the opportunity and had the confidence to make the decision to walk away from the comfort and security of his current role at a global leader in NTT Data. Tamer’s decision to join Loop as our CTO truly speaks volumes about where we are headed as a company. Having an established and proven world-class talent capable of driving our technology at a truly global commercialized scale gives me incredible confidence.”
Shafik Joins Loop Insights From NTT Data As a Result of a Flourishing Partnership Between the Two Companies
On December 17th, Loop Insights first announced a partnership with NTT DATA Corp of Japan (TYO:9613) with the goal of creating new recurring revenue streams for both companies, including the integration of Loop’s automated marketing capabilities with NTT Data’s NTT Smart Platform. The partnership between Loop and NTT Data has been beneficial for both parties and led directly to Shafik’s decision to join Loop Insights.
Most recently, Shafik spent 3 years as the Director of Solution Architecture at NTT Data, the world’s eighth-largest software company with a market cap of over US$20-billion, where he excelled as a digital transformation expert.
Shafik brings over 20 years of experience working in IT and eCommerce to the Loop Insights team, including 5 years spent working with leading Canadian multinational information technology consulting and systems integration company, CGI. As a digital transformation expert, Shafik has been instrumental in leading a number of established clients to update their digital infrastructure to keep pace with modern technology.
Posted by AGORACOM-JC
at 2:30 PM on Wednesday, January 27th, 2021
As many of you have been watching the astounding rise of GameStop (GME:NASDAQ) it’s hard not to take notice of a company whose stock has had a 52-week low of $2.57 to a recent high of $380.
You may ask what a Fortune 500 company and a digital-first omni-channel retailer who offers games and entertainment products in its over 5,000 stores and comprehensive e-commerce properties across 10 countries has in common with PlantX Life Inc. (the “Company” or “PlantX”) (VEGA:CSE) (PLTXF:OTC) an online/ brick and mortar one-stop-shop for everything plant-based has in common…
It’s simple. Ryan Cohen, GameStop (GME:NASDAQ) inside shareholder, Board Member and… Sean Dollinger, founder of PlantX Life (VEGA:CSE) (PLTXF:OTC). The relationship runs deep. Ryan Cohen and Sean Dollinger were 50/50 partners on 3 .coms. After the three websites, Cohen went on to start Chewy.com and Dollinger went on to start Namaste Technologies. Cohen exited Chewy.com with a highly publicized sale to (Petsmart (PETM: NASDAQ), Dollinger brought Namaste Technologies to a $1.2B market cap.
In August of 2020, Ryan Cohen stepped into GameStop (GME:NASDAQ), took a sizable position in the company (~12%) and obtained 3 board seats. The stock instantly attracted a cult-like following. As a result, the company’s shares went from $4 to over $380.
Sean Dollinger founded PlantX in December 2019. As of April 2020 the Company had no revenue to speak of. Fast forward 8 months to December 2020 and PlantX Life (VEGA:CSE) (PLTXF:OTC) generated gross monthly revenue of over $1M for the month. It’s interesting to point out that Cohen and Dollinger have very similar prowess especially within the e-commerce space. After-all, they learned everything about e-commerce together, and then went on their own paths to both build billion dollar e-commerce companies using the strategies they learned together.
PlantX Life (VEGA:CSE) (PLTXF:OTC) maintains a first mover advantage as the first (known) public company fully focused on the plant-based e-commerce space. The Company exhibits strong fundamentals with cash on balance sheet, no debt, low CapEx requirements and diverse revenue streams. The Company operates in three high-growth industries – the plant-based, e-commerce/technology and consumer-packaged goods sectors. PlantX continues strides for global reach with their intent to list on Nasdaq, evidence of the company’s commitment to investor accessibility and corporate growth.
Posted by AGORACOM
at 9:11 AM on Wednesday, January 27th, 2021
Lab study to demonstrate solubility technology applied to the Ivermectin drug can be applied as a broad therapeutic to immediately treat COVID-19
Commencing lab trial in late February 2021, with results anticipated in April 2021.
Mountain Valley MD Holdings Inc.(the “Company” or “MVMD“) (CSE: MVMD) (FRA: 20MP) is pleased to announce it has executed an agreement to conduct its Bio Safety Level 4 (“BSL-4”) lab study of COVID-19 viral clearance in transgenic mice designed to prove the superiority of the Company’s solubilized Ivermectin technology versus commercially available oral form in speed and efficacy of viral clearance. The agreement was signed January 26, 2021.
“This is a very significant project for MVMD and it will clearly demonstrate how our solubility technology applied to the Ivermectin drug can be applied as a broad therapeutic to immediately treat COVID-19, as well as its role in stopping the deadly spread of future pandemics that are certain to follow,” stated Dennis Hancock, President and CEO of Mountain Valley MD. “Quicksol™ allows us to imagine a world’s first as an injectable Ivermectin format for emergency front line usage as well as a rapid dissolve tablet that is administered for prevention like vitamin C around the world.”
There are less than thirty BSL-4 facilities in the world capable of performing this study and it is not unusual for projects to take up to three years to schedule. The Company was able to demonstrate the significance of its patented solubilized Ivermectin technology through its presentation of the superior pharmacokinetic data documented from two previously completed pre-clinical trials and was granted approval by the BSL-4 facility to commence this trial in late February 2021. The study results are anticipated in April 2021.
This study will be the first of its kind ever conducted with human grade solubilized Ivermectin anywhere in the world and its design was led by the Company’s key scientific advisor, Dr. John Clements. Dr. Clements is Emeritus Professor of Microbiology and Immunology at Tulane University School of Medicine and has over 35 years of experience in vaccine, immunology and infectious diseases research and development, with a distinguished scientific career focused on developing and evaluating vaccines for a wide range of infectious diseases globally.
Posted by AGORACOM
at 3:00 PM on Tuesday, January 26th, 2021
Commenced an infill auger drilling program at K4-K5 to tighten the historic auger sampling pattern
Grid decreased to 200 x 50m in order to better constrain individual gold zones
Tajiri Resources Corp. (the “Company”) (TSXV: TAJ) is pleased to provide an update to the ongoing exploration work at the Company’s 100% owned Reo Gold Property, Burkina Faso, West Africa.
After completing initial drilling of the Morley prospect where numerous hits were reported including hole MRTC0022’s 11 metres of 8.6 g/t Au including 3 metres at 30.9 g/t Au from 20 metres; the Company began power auger drilling and trenching at the K4-K5 Prospect, where historic wide spaced drill lines returned significant mineralised intersections including: 18m @ 2.5g/t; 44m @ 1.5g/t, 12m @ 5.0g/t, 4m @ 16.2g/t; 36m @ 1.3g/t, 16m @ 2.7g/t, 20m @ 1.7g/t 18m @ 2.5g/t, 20m @ 1.7g/t, 18m @ 1.6g/t 12m @ 4.1g/t. RC: 13m @ 2.2g/t, 6m @ 2.7g/t, 16m @ 2.0g/t, 10m @ 3.5g/t; 3m @ 11.5g/t, 2m @ 16.8g/t, over an area of 3 x 4km from within a larger area of gold in saprolite anomalism of approximately 9 x 4 km (see Figure 1).
Due to the massive scale of the prospect and previous wide spaced sampling programmes Tajiri commenced an infill auger drilling program at K4-K5 to tighten the historic auger sampling pattern from a 400 x 100m grid to a 200 x 50m grid in order to better constrain individual gold zones within the broad gold in saprolite anomaly and to also investigate individual larger areas of artisanal workings on 100 x 25m to 25 x 25m grid spacings on an east west grid. Because artisanal workings have largely not been sampled or drilled to date and because they potentially overly areas of significant gold mineralisation it was considered important to sample these areas and determine orientation of mineralisation prior to commencing more expensive RC / diamond drilling programs.
Posted by AGORACOM
at 2:23 PM on Tuesday, January 26th, 2021
VoPay’s payment tech platform gives Marble‘s customers an ideal solution to easily and rapidly incorporate EFT payments
simplifies the process for providing a single API integration to banking providers
Allows Marble to improve customer retention and reduce costs
Vancouver, B.C. – January 26, 2021 – Marble Financial Inc. (CSE:MRBL ); ( OTC:MRBLF); (CNSX:MRBL.CN); (“Marble” or the “Company”) a financial technology company that empowers Canadians’ toward a positive financial future, is pleased to announce that it has partnered with VoPay International Inc. (“VoPay”) to deliver its open banking payments solution with coverage for thousands of new and existing MyMarble customers.
This partnership which enables new payment options to consumers, simplifies the process for providing a single API integration to banking providers.
VoPay’s payment technology platform now provides Marble an ideal solution to enable customers to easily and rapidly incorporate electronic funds transfer (“EFT”) payments into their financial technology solutions. With VoPay’s integrated single payment API, Marble is able to improve customer retention and reduce costs, which results in rapidly expanded and streamlined payment options for MyMarble users and for the Company to expand its top-end revenue channels.
According to Payments Canada Methods and Trends (CPMT) 2020 report, EFT payments have increased and represent 61% of the total remote payments volume. This presents a growing preferred payment method by Canadians, something Marble has not been able to offer in the past.
“We are very excited about partnering with VoPay to add a new payment option to Marble’s growing customer base and revenue streams,” said Karim Nanji, CEO Marble. “VoPay is a leader in payment processing with a world-class product when it comes to speed and efficiency. Our partnership with VoPay will position Marble to support rapid growth, and together we can further support Canadians that do not have access to credit as a payment option.”
Posted by AGORACOM
at 12:13 PM on Tuesday, January 26th, 2021
Affinity Metals (AFF : TSXV) discusses rational for recently acquired Carscallen Extension property. The Carscallen Extension immediately adjoins the Melkior/Kirkland Lake Gold JV Carscallen Project located approximately 6 km west of Pan American Silver’s West Timmins Mine and approximately 25 KM West of Timmins.
Affinity announced the commencement of drilling on trend with the projected extension of the Shenkman-ZamZam gold system which has been the focus of the Melkior/Kirkland Lake Gold JV.
